‌

US Patent 10632112 Combination therapy for treatment of HBV infections

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Novira Therapeutics

Current Assignee

Novira Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106321120

Date of Patent

April 28, 2020

Patent Application Number

162352100

Date Filed

December 28, 2018

Patent Citations

‌

US Patent 10160743 Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

‌

US Patent 10081627 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

‌

US Patent 10196376 Hepatitis B antiviral agents

Patent Primary Examiner

‌

James D. Andereson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10632112 Combination therapy for treatment of HBV infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API